marijuana poisoning - Buffalo Academy of Veterinary Medicine
... these food items are now available in the licensed medical marijuana dispensaries and sold to registered medical marijuana patients. Marijuana is known by a variety of street names, “grass”, “weed”, “hemp”, “reefer”, “pot”, “herb”, “MJ”, and “Mary Jane”. “Sinsemilla” is seedless marijuana with a fai ...
... these food items are now available in the licensed medical marijuana dispensaries and sold to registered medical marijuana patients. Marijuana is known by a variety of street names, “grass”, “weed”, “hemp”, “reefer”, “pot”, “herb”, “MJ”, and “Mary Jane”. “Sinsemilla” is seedless marijuana with a fai ...
Naloxone fails to produce conditioned place aversion in
... regulating the `hedonic status' of the organism. The failure of NLX to induce aversion in MOR3/3 mice implies that NLX exerts its aversive e¡ect by blocking tonic activity of endogenous opioid ligands acting solely at the MOR since the total number and distribution of the DOR and U-opioid receptors ...
... regulating the `hedonic status' of the organism. The failure of NLX to induce aversion in MOR3/3 mice implies that NLX exerts its aversive e¡ect by blocking tonic activity of endogenous opioid ligands acting solely at the MOR since the total number and distribution of the DOR and U-opioid receptors ...
Qsymia (phentermine and topiramate extended release)
... adequate evidence that a vigorous weight loss program involving multi‐component behavioral interventions can lead to an average weight loss of 4 to 7 kg. This has been shown to improve glucose tolerance and other physiological risk factors for cardiovascular disease. Direct evidence about multiple ...
... adequate evidence that a vigorous weight loss program involving multi‐component behavioral interventions can lead to an average weight loss of 4 to 7 kg. This has been shown to improve glucose tolerance and other physiological risk factors for cardiovascular disease. Direct evidence about multiple ...
Psychostimulants and Cognition: A Continuum of Behavioral and
... producing addiction and psychosis. Cognitive and performance enhancement will be closely associated with low doses, less efficacious drugs, and slow (usually oral) administration, whereas addiction will be closely associated with high doses, more efficacious or potent drugs, and rapid routes of admi ...
... producing addiction and psychosis. Cognitive and performance enhancement will be closely associated with low doses, less efficacious drugs, and slow (usually oral) administration, whereas addiction will be closely associated with high doses, more efficacious or potent drugs, and rapid routes of admi ...
NIZORAL 200 MG TABLETS
... outcome or requiring liver transplantation have occurred with the use of oral ketoconazole (see section 4.8 Undesirable effects). Some patients had no obvious risk factors for liver disease. Cases have been reported that occurred within the first month of treatment, including some within the first w ...
... outcome or requiring liver transplantation have occurred with the use of oral ketoconazole (see section 4.8 Undesirable effects). Some patients had no obvious risk factors for liver disease. Cases have been reported that occurred within the first month of treatment, including some within the first w ...
the Paediatric EDACP tools
... was developed first. A pilot study4 undertaken in 2006 demonstrated that pathway use increased referrals for follow-up care and improved patient recollection of teaching done in the ED without a substantial increase in length of stay; there was also increased documentation of objective measures such ...
... was developed first. A pilot study4 undertaken in 2006 demonstrated that pathway use increased referrals for follow-up care and improved patient recollection of teaching done in the ED without a substantial increase in length of stay; there was also increased documentation of objective measures such ...
Addiction (1999) 94(5), 665-674
... for a minimum of 6 months, as stipulated in the inclusion criteria, and had been on the same dose for at least 4 weeks before participating in the study. Participants' reported illicit drug use was fairly typical of this treatment population; 72% of participants reported using at least one illicit d ...
... for a minimum of 6 months, as stipulated in the inclusion criteria, and had been on the same dose for at least 4 weeks before participating in the study. Participants' reported illicit drug use was fairly typical of this treatment population; 72% of participants reported using at least one illicit d ...
Slides 1-103 - Addiction Technology Transfer Center
... Has effects of typical opioid agonists at lower doses Produces a ceiling effect at higher doses Binds strongly to opioid receptor and is long-acting • Safe and effective therapy for opioid maintenance and detoxification in adults • Slow to dissociate from receptors so effects last even if one da ...
... Has effects of typical opioid agonists at lower doses Produces a ceiling effect at higher doses Binds strongly to opioid receptor and is long-acting • Safe and effective therapy for opioid maintenance and detoxification in adults • Slow to dissociate from receptors so effects last even if one da ...
Slide 1
... Has effects of typical opioid agonists at lower doses Produces a ceiling effect at higher doses Binds strongly to opioid receptor and is long-acting • Safe and effective therapy for opioid maintenance and detoxification in adults • Slow to dissociate from receptors so effects last even if one da ...
... Has effects of typical opioid agonists at lower doses Produces a ceiling effect at higher doses Binds strongly to opioid receptor and is long-acting • Safe and effective therapy for opioid maintenance and detoxification in adults • Slow to dissociate from receptors so effects last even if one da ...
Guidance for Industry Irritable Bowel Syndrome — Clinical Evaluation of Products for Treatment
... In recognition of the limitations of using a single-item patient-reported rating of change as a primary endpoint and based on the principles explained in the PRO guidance, we now recommend the development of a multi-item PRO instrument that captures all of the clinically important signs and symptoms ...
... In recognition of the limitations of using a single-item patient-reported rating of change as a primary endpoint and based on the principles explained in the PRO guidance, we now recommend the development of a multi-item PRO instrument that captures all of the clinically important signs and symptoms ...
260-670-1
... maternal 200 mg dose during labour maintains infant NVP >0.1 mg/l for several days. A 2 mg/kg NVP dose at 48 - 72 h keeps NVP >0.1 mg/l for a week in most infants (0.11 - 0.28 mg/l in 7-day-old infants). A study evaluating chronic NVP (4 mg/kg from birth to 14 days, then 8 mg/kg until 24 weeks) for ...
... maternal 200 mg dose during labour maintains infant NVP >0.1 mg/l for several days. A 2 mg/kg NVP dose at 48 - 72 h keeps NVP >0.1 mg/l for a week in most infants (0.11 - 0.28 mg/l in 7-day-old infants). A study evaluating chronic NVP (4 mg/kg from birth to 14 days, then 8 mg/kg until 24 weeks) for ...
ETOMIDATE INJECTION AF 33803 Format
... CLINICAL PHARMACOLOGY Etomidate is a hypnotic drug without analgesic activity. Intravenous injection of etomidate produces hypnosis characterized by a rapid onset of action, usually within one minute. Duration of hypnosis is dose dependent but relatively brief, usually three to five minutes when an ...
... CLINICAL PHARMACOLOGY Etomidate is a hypnotic drug without analgesic activity. Intravenous injection of etomidate produces hypnosis characterized by a rapid onset of action, usually within one minute. Duration of hypnosis is dose dependent but relatively brief, usually three to five minutes when an ...
Topamax tablet - PIO Nas - Badan Pengawas Obat dan Makanan
... Others: TOPAMAX, when used concomitantly with other agents predisposing to nephrolithiasis, may increase the risk of nephrolithiasis. While using TOPAMAX, agents like these should be avoided since they may create a physiological environment that increases the risk of renal stone formation. Overdose ...
... Others: TOPAMAX, when used concomitantly with other agents predisposing to nephrolithiasis, may increase the risk of nephrolithiasis. While using TOPAMAX, agents like these should be avoided since they may create a physiological environment that increases the risk of renal stone formation. Overdose ...
Light and Electron Microscopic Study on the Effect of
... Introduction: Lithium carbonate is the treatment of choice for acute manic episodes. It is often referred to as an antimanic drug as it prevents mood swings in patients with manic- depressive disorder. Thyroid disturbances during lithium treatment had been reported. Aim of the Work: This research wa ...
... Introduction: Lithium carbonate is the treatment of choice for acute manic episodes. It is often referred to as an antimanic drug as it prevents mood swings in patients with manic- depressive disorder. Thyroid disturbances during lithium treatment had been reported. Aim of the Work: This research wa ...
NYMALIZE PRODUCT FACT SHEET
... Nimodipine has been shown to have a teratogenic effect in two studies in rabbit. In one study, incidences of malformations and stunted fetuses were increased at oral doses of 1 mg/kg/day and 10 mg/kg/day administered throughout organogenesis but not at 3 mg/kg/day. In the second study, an increased ...
... Nimodipine has been shown to have a teratogenic effect in two studies in rabbit. In one study, incidences of malformations and stunted fetuses were increased at oral doses of 1 mg/kg/day and 10 mg/kg/day administered throughout organogenesis but not at 3 mg/kg/day. In the second study, an increased ...
Psychiatric Prescribing in College Health: Anxiety and
... distinguishing them from conditions that require different treatment Medication for anxiety – SSRI’s, benzodiazepines, other drugs Treatment tips & when to refer ...
... distinguishing them from conditions that require different treatment Medication for anxiety – SSRI’s, benzodiazepines, other drugs Treatment tips & when to refer ...
Stimulants
... equally effective. Immediate-release Ritalin is short acting and begins to work in 30–60 minutes after administration, with duration of 2–5 hours. The advantage is that it works quickly, but the duration of action is short and requires dosing two or three times a day. Similarly, Dexedrine is a short ...
... equally effective. Immediate-release Ritalin is short acting and begins to work in 30–60 minutes after administration, with duration of 2–5 hours. The advantage is that it works quickly, but the duration of action is short and requires dosing two or three times a day. Similarly, Dexedrine is a short ...
TCI: TOOL OR TOY
... This study involved 18 patients. Despite full details of this study not being published, it appears that it included few elderly or obese patients. Over the years, some adjustments were made to this model, several of them never published in peer reviewed journals. The Schnider model was derived from ...
... This study involved 18 patients. Despite full details of this study not being published, it appears that it included few elderly or obese patients. Over the years, some adjustments were made to this model, several of them never published in peer reviewed journals. The Schnider model was derived from ...
SELEGILINE
... in Parkinson’s disease • At doses above 10 mg/day (oral), selegiline may become nonselective and inhibit both MAO-A and MAO-B • At doses above 30 mg/day (oral), selegiline may have antidepressant properties • Patients receiving high oral doses may need to be evaluated periodically for effects on the ...
... in Parkinson’s disease • At doses above 10 mg/day (oral), selegiline may become nonselective and inhibit both MAO-A and MAO-B • At doses above 30 mg/day (oral), selegiline may have antidepressant properties • Patients receiving high oral doses may need to be evaluated periodically for effects on the ...
Amidate™ (Etomidate Injection, USP) (2 mg/mL)
... about 20% of the patients, with considerable difference in the reported incidence (1.2% to 42%). This pain is usually described as mild to moderate in severity but it is occasionally judged disturbing. The observation of venous pain is not associated with a more than usual incidence of thrombosis or ...
... about 20% of the patients, with considerable difference in the reported incidence (1.2% to 42%). This pain is usually described as mild to moderate in severity but it is occasionally judged disturbing. The observation of venous pain is not associated with a more than usual incidence of thrombosis or ...
Patient compliance in a clinical trial with inhaled budesonide in
... supervision with extra motivation and help. In the present study, the children were repeatedly encouraged and reminded to take their medication as prescribed at each visit every four weeks during the study. Inhalation techniques were checked, and possible problems regarding the treatment were discus ...
... supervision with extra motivation and help. In the present study, the children were repeatedly encouraged and reminded to take their medication as prescribed at each visit every four weeks during the study. Inhalation techniques were checked, and possible problems regarding the treatment were discus ...
Study protocol: a phase III randomised, double-blind
... study protocol written by the Palliative Care Clinical Studies Collaborative (PaCCSC).33 The study will report against CONSORT guidelines.34 35 ...
... study protocol written by the Palliative Care Clinical Studies Collaborative (PaCCSC).33 The study will report against CONSORT guidelines.34 35 ...
FENTANYL CITRATE INJECTION, USP
... meperidine. Histamine assays and skin wheal testing in man indicate that clinically significant histamine release rarely occurs with fentanyl. Recent assays in man show no clinically significant histamine release in dosages up to 50 mcg/kg (0.05 mg/kg) (1 mL/kg). Fentanyl preserves cardiac stability ...
... meperidine. Histamine assays and skin wheal testing in man indicate that clinically significant histamine release rarely occurs with fentanyl. Recent assays in man show no clinically significant histamine release in dosages up to 50 mcg/kg (0.05 mg/kg) (1 mL/kg). Fentanyl preserves cardiac stability ...
Detection Times of Drugs of Abuse in Blood, Urine
... Benzoylecgonine, one of the main metabolites of cocaine, is positive in urine for 1 to 2 days after an intravenous administration of 20 mg.33 After a higher dose (1.5 mg/kg) taken intranasally, the detection time is 2 to 3 days.34 In a study of 18 individuals housed for up to 14 days on a closed res ...
... Benzoylecgonine, one of the main metabolites of cocaine, is positive in urine for 1 to 2 days after an intravenous administration of 20 mg.33 After a higher dose (1.5 mg/kg) taken intranasally, the detection time is 2 to 3 days.34 In a study of 18 individuals housed for up to 14 days on a closed res ...
Interactions between Grapefruit Juice and Calcium Channel
... The extent of interaction between calcium channel antagonists and grapefruit juice varies widely among drugs. Coadministration of calcium channel antagonists with grapefruit juice can elevate the bioavailability of drugs and alter pharmacokinetic parameters of the drug. A calcium channel antagonist ...
... The extent of interaction between calcium channel antagonists and grapefruit juice varies widely among drugs. Coadministration of calcium channel antagonists with grapefruit juice can elevate the bioavailability of drugs and alter pharmacokinetic parameters of the drug. A calcium channel antagonist ...